The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

In a major boost for infant health, the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA (clesrovimab-cfor) , a ...

The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year ...

Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.

The FDA approved the monoclonal antibody clesrovimab-cfor for the prevention of respiratory syncytial virus lower respiratory ...

The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment.

Antibiotic use in preterm infants is linked to gut microbiome changes, increasing susceptibility to infections and impacting ...

Aqua Illinois advises University Park, Peotone and Kankakee residents not to give tap water to infants due to high nitrate ...

Water sampling results done Saturday revealed nitrate levels of 11.9 milligrams per liter, according to Aqua Water. The ...

Screening can now determine their risk for an ever-growing list of conditions — including ones we can’t do much about.